Dublin, March 13, 2026 (GLOBE NEWSWIRE)-- The "Roferon-a Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering.
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have divulged stimulator of interferon genes protein (STING; TMEM173) antagonists reported to be useful for the treatment of cancer, autoimmune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results